0001209191-19-021363.txt : 20190326
0001209191-19-021363.hdr.sgml : 20190326
20190326184558
ACCESSION NUMBER: 0001209191-19-021363
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190325
FILED AS OF DATE: 20190326
DATE AS OF CHANGE: 20190326
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Giraudo Bryan
CENTRAL INDEX KEY: 0001740847
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38796
FILM NUMBER: 19706282
MAIL ADDRESS:
STREET 1: 7707 GATEWAY BOULEVARD, SUITE 140
CITY: NEWARK
STATE: CA
ZIP: 94560
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Gossamer Bio, Inc.
CENTRAL INDEX KEY: 0001728117
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 475461709
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3013 SCIENCE PARK
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (858) 922-0718
MAIL ADDRESS:
STREET 1: 3013 SCIENCE PARK
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-03-25
0
0001728117
Gossamer Bio, Inc.
GOSS
0001740847
Giraudo Bryan
3013 SCIENCE PARK ROAD
SAN DIEGO
CA
92121
0
1
0
0
Chief Financial Officer
Stock Option (right to buy)
22.10
2019-03-25
4
A
0
145000
0.00
A
2029-03-25
Common Stock
145000
145000
D
25% of the total number of shares subject to the option will vest on March 25, 2020 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Corporation on each such vesting date.
/s/ Jeff Boerneke, Attorney-in-Fact
2019-03-26